Richmond University Medical Center is a hospital in West New Brighton, Staten Island, New York City. The hospital occupies the buildings that were formerly St. Vincent's Medical Center, which closed in 2006. It is affiliated with the Icahn School of Medicine at Mount Sinai and the Mount Sinai Health System.

There are 448 beds in Richmond University Medical Center.

During the past decade, Richmond University Medical Center conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 8 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 6 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Richmond University Medical Center" #1 sponsor was "Richmond University Medical Center" with 5 trials, followed by "National Cancer Institute (NCI)" with 3 trials sponsored, "American Regent, Inc." with 2 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "CTI BioPharma" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Richmond University Medical Center" #1 collaborator was "Cancer and Leukemia Group B" with 2 trials as a collaborator, "Duke Clinical Research Institute" with 2 trials as a collaborator, "North Central Cancer Treatment Group" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator and "United States Department of Defense" with 2 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Richmond University Medical Center" are "COVID-19" (3 trials), "Breast Adenocarcinoma" (2 trials), "Colorectal Cancer" (2 trials), "Heart Failure" (2 trials) and "Lung Cancer" (2 trials). Many other conditions were trialed in "Richmond University Medical Center" in a lesser frequency.

Most popular intervention types in "Richmond University Medical Center" are "Drug" (20 trials), "Other" (9 trials), "Biological" (4 trials), "Device" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Laboratory Biomarker Analysis" (3 trials), "Gemcitabine" (2 trials), "Quality-of-Life Assessment" (2 trials) and "Sargramostim" (2 trials). Other intervention names were less common.

The vast majority of trials in "Richmond University Medical Center" are 21 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Richmond University Medical Center". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Richmond University Medical Center, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Richmond University Medical Center, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".